Learn More about OJJAARA | OJJAARA (momelotinib)
网页Discover OJJAARA (momelotinib), a treatment option for adults who have myelofibrosis (MF) with anemia. Learn about the study results for OJJAARA. See full Prescribing Info & Patient Info.
Administration Tips | OJJAARA (momelotinib)
网页Access OJJAARA (momelotinib) to find info to questions about how to take OJJAARA and more. See full Prescribing Info and Patient Info.
Risks and Side Effects | OJJAARA (momelotinib)
网页Learn about possible risks & side effects associated with OJJAARA. See full Prescribing Info and Patient Info. Access the website to learn more about study results for OJJAARA (momelotinib).
What is Myelofibrosis? | OJJAARA (momelotinib)
网页Discover a treatment option. OJJAARA is the first and only FDA-approved treatment option specifically for adults who have certain types of MF with anemia. SEE OJJAARA BENEFITS. Approved Use. OJJAARA is a prescription medicine used to treat adults with certain types of myelofibrosis (MF) who have anemia.
How OJJAARA works
网页OJJAARA is the first and only FDA-approved treatment specifically for adults with certain types of myelofibrosis (MF) who have anemia. SEE OJJAARA BENEFITS. Approved Use. OJJAARA is a prescription medicine used to treat adults with certain types of myelofibrosis (MF) who have anemia.
Study Results for OJJAARA | OJJAARA (momelotinib)
网页View the study results for OJJAARA (momelotinib). Talk to your doctor to find out if OJJAARA could be right for you. See full Prescribing Info and Patient Info.
网页OJJAARA is the first and only FDA-approved treatment specifically for adults with certain types of MF who have anemia. It is not known if OJJAARA is safe and effective in children.
Myelofibrosis Resources | OJJAARA (momelotinib)
网页Discover OJJAARA (momelotinib) to access additional patient support and resources. See full Prescribing Info and Patient Info.
Reimbursement support - OJJAARA
网页Offer co-pay assistance for eligible, commercially insured patients who may receive their OJJAARA for as little as $0 up to an annual program maximum of $26,000. Provide information about other organizations or independent foundations that may be able to help with OJJAARA costs.
网页OJJAARA is the first and only FDA-approved treatment specifically for adults with certain types of myelofibrosis (MF) who have anemia. It is not known if OJJAARA is safe and efective in children. Your doctor prescribed OJJAARA to help treat your MF.